Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

Br J Cancer · 2010 · PMC2966632 · PMID 20717115

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP =0.24not close (p > 0.1)

After the first treatment cycle, CgA levels decreased (median, 121 ng ml −1 ; 95% CI: 65–212), even though the difference did not reach statistical significance ( P =0.24, Wilcoxon test), and at this time point tended to correlate inversely with survival ( r =−0.44; P =0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.